A trial for detecting and promoting physical activity for sedentary patients with breast cancer undergoing adjuvant chemotherapy

Not Applicable

Completed

• Conditions: Breast cancer receiving adjuvant chemotherapy; Cancer; Malignant neoplasm of breast

• Registration Number: ISRCTN13816000
• Lead Sponsor: ovo Nordic Foundation (Novo Nordisk Fonden) (Denmark)

Brief Summary

2019 results in https://pubmed.ncbi.nlm.nih.gov/31354000/ (added 17/12/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-03-13
• Study Completion: 2017-03-31
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 153

Inclusion Criteria

1. Patients diagnosed with breast cancer (stage I - III) in adjuvant chemotherapy
2. WHO performance status of 0 or 1
3. Aged 18 + years who do not meet criteria for recommended physical activity levels of 150 min / week of moderate leisure time physical activity, and exercises at least 20 minutes of strenuous physical activity twice a week.

Exclusion Criteria

1. Patients with myocardial infarction within the past three months
2. Symptomatic heart failure or contraindication for moderate to strenuous physical activity noted in the medical records.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Maximum oxygen uptake - VO2-peak (Measured baseline and at 6, 12 and 39 weeks).